Spontaneous regression of natural killer cell lymphoma

Journal of Clinical Pathology

Volumn 62, Issue 7, 2009, Pages 647-650

  Isobe, Y ^a   Aritaka, N ^a   Sasaki, M ^a   Oshimi, K ^a   Sugimoto, Koichi ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RELAPSE; CASE REPORT; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CLINICAL FEATURE; COURSE EVALUATION; CYTOTOXIC T LYMPHOCYTE; ERYTHEMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOMA; MULTIPLE CYCLE TREATMENT; NATURAL KILLER CELL; NATURAL KILLER CELL LYMPHOMA; PRIORITY JOURNAL; SKIN PRURITUS; SKIN SWELLING; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNITY; TUMOR REGRESSION;

AGED; FEMALE; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; LYMPHOMA, EXTRANODAL NK-T-CELL; NEOPLASM REGRESSION, SPONTANEOUS; SKIN NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 67650491319     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2008.062976     Document Type: Article

References (10)

1. Swerdlow SH, Campo E, Harris NL, et al, eds. WHO classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edn. World Health Organization Classification of Tumours. Vol.2. Lyon: IARC Press, 2008.
2. Oshimi K. Progress in understanding and managing natural killer-cell malignancies. Br J Haematol 2007;139:532-544 (Pubitemid 350043813)
3. Drobyski WR, Qazi R. Spontaneous regression in non-Hodgkin's lymphoma: clinical and pathogenetic consideration. Am J Hematol 1989;31:138-141 (Pubitemid 19155229)
4. Kimura H. Pathogenesis of chronic active Epstein-Barr virus infection: Is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol 2006;16:251-261
5. Iwatsuki K, Satoh M, Yamamoto T, et al. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Arch Dermatol 2006;142:587-595 (Pubitemid 43727549)
6. Asada H. Hypersensitivity to mosquito bites: a unique pathogenic mechanism linking Epstein-Barr virus infection, allergy and oncogenesis. J Dermatol Sci 2007;45:153-160 (Pubitemid 46216043)
7. International T-cell lymphoma project. International T-cell and natural killer/T-cell lymphoma study. Pathology findings and clinical outcome. J Clin Oncol 2008;26:4124-4130
8. Demaria S, Ng B, DevittML, et al. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Rad Oncol Biol Phys 2004;58:862-870 (Pubitemid 38221143)
9. Reits EA, Hodge JW, Herberts CA, et al. Radiation modulates the peptide repertoire enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med 2006;203:1259-1271 (Pubitemid 43736595)
10. Demachi-Okamura A, Ito Y, Akatsuka Y, et al. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocyte targeting EBV-carrying natural killer cell malignancies. Eur J Immunol 2006;36:593-602.